Fund Holdings — Frazier Life Sciences Management, L.P.

Total Portfolio Value:
$1.87B
Total Bought:
$275.05M
Total Sold:
$77.28M
Net Transaction:
+$197.77M
Notable People:
James Newman Topper, Patrick James Heron, Daniel Estes, James Brush, Albert (Nmn) Cha, Frazier Life Sciences Management,
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Mirum Pharmaceuticals, Inc.(MIRM)6,470,3926,495,392+25,000$204.46M$191.74M10.25%-$12.72M
Hillevax Inc9,781,4729,781,4720$131.56M$156.99M8.39%+$25.43M
Newamsterdam Pharma Company
ORDINARY SHARES
12,131,70512,131,7050$112.22M$135.51M7.25%+$23.29M
Krystal Biotech, Inc.(KRYS)988,460988,4600$114.66M$122.63M6.56%+$7.97M
BridgeBio Pharma, Inc.(BBIO)2,725,9492,725,9490$71.88M$110.05M5.88%+$38.16M
Rhythm Pharmaceuticals, Inc.(RYTM)2,371,3042,371,3040$54.36M$109.01M5.83%+$54.65M
Phathom Pharmaceuticals, Inc.(PHAT)10,109,27910,109,2790$104.83M$92.30M4.93%-$12.54M
Vaxcyte, Inc.(PCVX)1,164,4051,164,4050$59.36M$73.12M3.91%+$13.76M
Verona Pharma PlcADS3,014,3493,014,3490$49.13M$59.93M3.20%+$10.79M
Alpine Immune Sciences Inc2,985,7573,131,008+145,251$34.19M$59.68M3.19%+$25.49M
Apellis Pharmaceuticals Inc
COM
614,043885,165+271,122$23.36M$52.99M2.83%+$29.63M
Rocket Pharmaceuticals, Inc.(RCKT)1,403,0131,523,013+120,000$28.75M$45.64M2.44%+$16.90M
Disc Medicine, Inc.(IRON)655,000785,000+130,000$30.77M$45.34M2.42%+$14.57M
Kalvista Pharmaceuticals Inc3,238,8593,622,294+383,435$31.19M$44.37M2.37%+$13.18M
Tarsus Pharmaceuticals, Inc.(TARS)1,787,5271,787,5270$31.76M$36.20M1.94%+$4.43M
Edgewise Therapeutics, Inc.(EWTX)849,0222,667,203+1,818,181$4.86M$29.18M1.56%+$24.31M
Revolution Medicines, Inc.(RVMD)997,455997,4550$27.61M$28.61M1.53%+$997.5K
An2 Therapeutics Inc1,388,8891,388,8890$22.33M$28.46M1.52%+$6.13M
Arcutis Biotherapeutics, Inc.(ARQT)8,684,2328,764,232+80,000$46.11M$28.31M1.51%-$17.80M
Aerovate Therapeutics Inc1,204,8671,204,8670$16.35M$27.27M1.46%+$10.92M
Autolus Therapeutics plcADS(AUTL)3,746,8573,746,8570$8.73M$24.13M1.29%+$15.40M
MacroGenics, Inc.(MGNX)1,803,2042,401,704+598,500$8.40M$23.10M1.24%+$14.70M
Acadia Pharmaceuticals Inc630,897730,917+100,020$13.15M$22.89M1.22%+$9.74M
89bio Inc02,000,000+2,000,000$0$22.34M1.19%+$22.34M
Merus N V746,479746,4790$17.60M$20.53M1.10%+$2.93M
ORIC Pharmaceuticals, Inc.(ORIC)2,142,8552,142,8550$12.96M$19.71M1.05%+$6.75M
Anaptysbio Inc899,700899,7000$16.16M$19.27M1.03%+$3.11M
Savara Inc.(SVRA)4,000,0004,000,0000$15.12M$18.80M1.01%+$3.68M
Soleno Therapeutics Inc464,937464,9370$13.72M$18.71M1.00%+$4.99M
Cerevel Therapeutics Hldng I393,000393,0000$8.58M$16.66M0.89%+$8.08M
Deciphera Pharmaceuticals In370,0001,021,800+651,800$4.71M$16.48M0.88%+$11.78M
Madrigal Pharmaceuticals, Inc.(MDGL)069,406+69,406$0$16.06M0.86%+$16.06M
Dyne Therapeutics, Inc.(DYN)01,184,840+1,184,840$0$15.76M0.84%+$15.76M
Silence Therapeutics plcADS(SLN)881,173881,1730$8.66M$15.31M0.82%+$6.64M
Tyra Biosciences, Inc.(TYRA)1,028,0131,026,420-1,593$14.16M$14.22M0.76%+$60.2K
Crinetics Pharmaceuticals In1,589,931397,483-1,192,448$47.28M$14.14M0.76%-$33.14M
Structure Therapeutics IncADS0317,190+317,190$0$12.93M0.69%+$12.93M
Arvinas, Inc.(ARVN)285,331285,3310$5.60M$11.74M0.63%+$6.14M
Cogent Biosciences, Inc.(COGT)1,501,3831,995,267+493,884$14.64M$11.73M0.63%-$2.91M
Agios Pharmaceuticals, Inc.(AGIO)292,002523,166+231,164$7.23M$11.65M0.62%+$4.42M
Apogee Therapeutics Inc400,000400,0000$8.52M$11.18M0.60%+$2.66M
Trevi Therapeutics, Inc.(TRVI)6,881,0907,381,090+500,000$15.00M$9.89M0.53%-$5.11M
Theseus Pharmaceuticals Inc2,248,1942,118,051-130,143$6.05M$8.58M0.46%+$2.53M
Intellia Therapeutics, Inc.(NTLA)203,684203,6840$6.44M$6.21M0.33%-$230.2K
Mirati Therapeutics Inc080,000+80,000$0$4.70M0.25%+$4.70M
Bluebird Bio Inc1,709,9071,709,9070$5.20M$2.36M0.13%-$2.84M
Gritstone Bio Inc1,430,8781,030,878-400,000$2.46M$2.10M0.11%-$358.1K
Newamsterdam Pharma CompanyW EXP 11 22 202
*W EXP 99/99/999
500,333500,3330$950.6K$1.57M0.08%+$615.4K
Aclaris Therapeutics, Inc.(ACRS)264,377264,3770$1.81M$277.6K0.01%-$1.53M
ADC THERAPEUTICS SASHS(ADCT)1,647,0300-1,647,030$1.48M$0—-$1.48M
ENLIVEN THERAPEUTICS INCCOM1,050,4830-1,050,483$14.35M$0—-$14.35M
PASSAGE BIO INCCOM(PASG)1,758,2190-1,758,219$1.16M$0—-$1.16M
PROTHENA CORP PLCSHS
SHS
127,9000-127,900$6.17M$0—-$6.17M
REPLIMUNE GROUP INCCOM(REPL)386,7620-386,762$6.62M$0—-$6.62M
SUTRO BIOPHARMA INCCOM(STRO)780,0000-780,000$2.71M$0—-$2.71M
SYNDAX PHARMACEUTICALS INCCOM(SNDX)600,0000-600,000$8.71M$0—-$8.71M
Page 1 of 1
Frazier Life Sciences Management, L.P. — 13F Holdings — Q4 2023 | TickerTrail